
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1045 | 979 | 1055 | 1256 | 1755 | 1725 |
Fund Return | 4.51% | -2.12% | 5.54% | 7.9% | 11.9% | 5.6% |
Place in category | 976 | 1169 | 921 | 562 | 388 | 242 |
% in Category | 44 | 56 | 44 | 31 | 25 | 23 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU2197358042 | 2.92B | -14.30 | 8.42 | - | ||
Cleome Index USA Equities R EUR Acc | 2.92B | -14.36 | 8.18 | 10.98 | ||
Cleome Index USA Equities Y EUR Acc | 2.92B | -14.66 | 7.04 | 10.08 | ||
Cleome Index USA Equities Z EUR Acc | 2.92B | -14.27 | 8.51 | 11.36 | ||
Candriam Equities L Global Demograp | 2.12B | -11.63 | 5.94 | 8.50 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund A Acc EUR | 177.46M | 4.78 | 9.19 | 4.29 | ||
European Growth Fund E Acc EUR | 23.79M | 4.51 | 8.35 | 3.51 | ||
European Growth Fund Y Acc EUR | 226.67M | 5.09 | 10.10 | 5.16 | ||
European Growth Fund Y DIST EUR | 69.08M | 5.09 | 10.11 | 5.16 | ||
European Growth Fund A DIST Eue | 6.96B | 4.81 | 9.19 | 4.29 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SAP | DE0007164600 | 2.48 | 266.250 | +1.16% | |
Nestle | CH0038863350 | 2.38 | 86.48 | -0.13% | |
ASML Holding | NL0010273215 | 2.25 | 668.40 | -2.02% | |
Roche Holding Participation | CH0012032048 | 2.06 | 259.70 | +1.05% | |
AstraZeneca | GB0009895292 | 2.00 | 10,330.0 | +1.85% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review